Ledger.Open graph →
SEC Form D · filed May 19, 2020

Intec Pharma Ltd

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
JERUSALEM, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

John W. Kozarich · JERUSALEM, L3DirectorNir A. Sassi · JERUSALEM, L3ExecHila W. Karah · JERUSALEM, L3DirectorWilliam B. Hayes · JERUSALEM, L3DirectorWalt A. Linscott · JERUSALEM, L3ExecR. M. Gendreau · JERUSALEM, L3ExecJeffrey A. Meckler · JERUSALEM, L3Exec · DirectorRoger J. Pomerantz · JERUSALEM, L3DirectorAnthony J. Maddaluna · JERUSALEM, L3DirectorNadav A. Navon · JERUSALEM, L3ExecWilliam B. Hayes · JERUSALEM, L3DirectorJohn W. Kozarich · JERUSALEM, L3DirectorNir A. Sassi · JERUSALEM, L3ExecHila W. Karah · JERUSALEM, L3DirectorNadav A. Navon · JERUSALEM, L3ExecWalt A. Linscott · JERUSALEM, L3ExecR. M. Gendreau · JERUSALEM, L3ExecJeffrey A. Meckler · JERUSALEM, L3Exec · DirectorRoger J. Pomerantz · Jupiter, FLDirectorAnthony J. Maddaluna · JERUSALEM, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗